{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T13:23:53Z","timestamp":1787318633630,"version":"build-2736575974"},"reference-count":134,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T00:00:00Z","timestamp":1771804800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["24fk0210154"],"award-info":[{"award-number":["24fk0210154"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>In 2023, the terminology of metabolic dysfunction-associated steatotic liver disease (MASLD) was proposed. MASLD uses metabolic abnormalities as an inclusion criterion. On the other hand, sarcopenia is defined by decrease in muscle mass and muscle strength. Skeletal muscle can be affected by insulin resistance (IR), and it is the largest site of insulin-stimulated glucose disposal. In recent years, advances in treatment have extended the life expectancy of patients with chronic liver disease (CLD). Due to the aging population, aging-related primary sarcopenia is expected to increase. On the other hand, liver fibrosis is an important treatment target associated with the onset of serious adverse events and poor prognosis in MASLD. The liver is the central organ for nutrition and metabolism, and patients with CLD may develop secondary sarcopenia due to various nutritional and metabolic disorders unrelated to aging. There is a strong correlation between sarcopenia, muscle fatty degeneration, liver fibrosis and IR in MASLD. MASLD and sarcopenia have a bidirectional relationship, forming a vicious cycle. In this review, we will summarize the relationship between MASLD and sarcopenia based on the current knowledge.<\/jats:p>","DOI":"10.3390\/jcm15041661","type":"journal-article","created":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T08:58:21Z","timestamp":1771837101000},"page":"1661","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Metabolic Dysfunction-Associated Steatotic Liver Disease and Sarcopenia: Review of Literature"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-0488-3297","authenticated-orcid":false,"given":"Hiroki","family":"Nishikawa","sequence":"first","affiliation":[{"name":"Second Department of Internal Medicine, Osaka Medical and Pharmaceutical University, Takatsuki 569-8686, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5527-6555","authenticated-orcid":false,"given":"Soo Ki","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Kobe Asahi Hospital, Kobe 653-8501, Hyogo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachiyo","family":"Yoshio","sequence":"additional","affiliation":[{"name":"Department of Human Immunology and Translational Research, National Institute of Global Health and Medicine, Japan Institute for Health Security, Shinjukuku 162-0052, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2915-7875","authenticated-orcid":false,"given":"Akira","family":"Asai","sequence":"additional","affiliation":[{"name":"Second Department of Internal Medicine, Osaka Medical and Pharmaceutical University, Takatsuki 569-8686, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,2,23]]},"reference":[{"key":"ref_1","first-page":"283","article-title":"Nonalcoholic fatty liver disease","volume":"8","author":"Schaffner","year":"1986","journal-title":"Prog. Liver Dis."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2974","DOI":"10.3748\/wjg.v24.i27.2974","article-title":"Pathogenesis of non-alcoholic fatty liver disease in children and adolescence: From \u201ctwo hit theory\u201d to \u201cmultiple hit model\u201d","volume":"24","author":"Fang","year":"2018","journal-title":"World J. Gastroenterol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","article-title":"The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): A systematic review","volume":"77","author":"Younossi","year":"2023","journal-title":"Hepatology"},{"key":"ref_4","first-page":"389","article-title":"Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999-2019: A systematic review and meta-analysis","volume":"4","author":"Li","year":"2019","journal-title":"Lancet Gastroenterol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1136\/gutjnl-2023-330595","article-title":"MASLD: A systemic metabolic disorder with cardiovascular and malignant complications","volume":"73","author":"Targher","year":"2024","journal-title":"Gut"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.jhep.2023.11.004","article-title":"Global survey of stigma among physicians and patients with nonalcoholic fatty liver disease","volume":"80","author":"Younossi","year":"2024","journal-title":"J. Hepatol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1111\/hepr.13688","article-title":"Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis 2020","volume":"51","author":"Tokushige","year":"2021","journal-title":"Hepatol. Res."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"e155","DOI":"10.1016\/j.jhep.2023.12.030","article-title":"Almost identical values of various non-invasive indexes for hepatic fibrosis and steatosis between NAFLD and MASLD in Asia","volume":"80","author":"Nakano","year":"2024","journal-title":"J. Hepatol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1056\/NEJMoa2309000","article-title":"A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis","volume":"390","author":"Harrison","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1002\/ueg2.70072","article-title":"The Rising Global Burden of MASLD and Other Metabolic Diseases (2000\u20132021)","volume":"13","author":"Danpanichkul","year":"2025","journal-title":"United Eur. Gastroenterol. J."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1001\/jamainternmed.2024.6431","article-title":"A Clinical Update on MASLD","volume":"185","author":"Zhang","year":"2025","journal-title":"JAMA Intern. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/hepr.14127","article-title":"Fatty liver index and somatic composition in subjects receiving medical health checkup","volume":"55","author":"Ushiro","year":"2025","journal-title":"Hepatol. Res."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.jamda.2019.12.012","article-title":"Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia Diagnosis and Treatment","volume":"21","author":"Chen","year":"2020","journal-title":"J. Am. Med. Dir. Assoc."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1038\/s43587-025-01004-y","article-title":"A focus shift from sarcopenia to muscle health in the Asian Working Group for Sarcopenia 2025 Consensus Update","volume":"5","author":"Chen","year":"2025","journal-title":"Nat. Aging"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1016\/j.clnu.2024.07.006","article-title":"The prevalence and effects of sarcopenia in patients with metabolic dysfunction-associated steatotic liver disease (MASLD): A systematic review and meta-analysis","volume":"43","author":"Li","year":"2024","journal-title":"Clin. Nutr."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"156","DOI":"10.3892\/ijmm.2021.4989","article-title":"Pathophysiology and mechanisms of primary sarcopenia (Review)","volume":"48","author":"Nishikawa","year":"2021","journal-title":"Int. J. Mol. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1111\/hepr.12774","article-title":"Japan Society of Hepatology guidelines for sarcopenia in liver disease (1st edition): Recommendation from the working group for creation of sarcopenia assessment criteria","volume":"46","author":"Nishikawa","year":"2016","journal-title":"Hepatol. Res."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1053\/j.gastro.2023.01.033","article-title":"Global Epidemiology and Genetics of Hepatocellular Carcinoma","volume":"164","author":"Toh","year":"2023","journal-title":"Gastroenterology"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.cgh.2024.08.020","article-title":"Global Prevalence of Advanced Liver Fibrosis and Cirrhosis in the General Population: A Systematic Review and Meta-analysis","volume":"23","author":"Zamani","year":"2025","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1111\/hepr.14047","article-title":"Etiological changes of liver cirrhosis and hepatocellular carcinoma-complicated liver cirrhosis in Japan: Updated nationwide survey from 2018 to 2021","volume":"54","author":"Enomoto","year":"2024","journal-title":"Hepatol. Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"R673","DOI":"10.1152\/ajpregu.00561.2007","article-title":"Skeletal muscle insulin resistance: Role of inflammatory cytokines and reactive oxygen species","volume":"294","author":"Wei","year":"2008","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"115082","DOI":"10.1016\/j.intimp.2025.115082","article-title":"Role of leptin and adiponectin in immune response and inflammation","volume":"161","author":"Liu","year":"2025","journal-title":"Int. Immunopharmacol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"eaat3987","DOI":"10.1126\/science.aat3987","article-title":"Interleukin-13 drives metabolic conditioning of muscle to endurance exercise","volume":"368","author":"Knudsen","year":"2020","journal-title":"Science"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1002\/jcsm.13548","article-title":"Roles of programmed death-1 and muscle innate lymphoid cell-derived interleukin 13 in sepsis-induced intensive care unit-acquired weakness","volume":"15","author":"Akama","year":"2024","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Atabieke, F., Li, X.J., Aierken, A., Li, J., Zhang, Y., Aizezi, Y., Gao, H.L., and Zhang, Z.Q. (2024). Association between frailty and hepatic fibrosis in NAFLD among middle-aged and older adults: Results from NHANES 2017\u20132020. Front. Public Health, 12.","DOI":"10.3389\/fpubh.2024.1330221"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s12072-019-09964-1","article-title":"Relationship between relative skeletal muscle mass and nonalcoholic fatty liver disease: A systematic review and meta-analysis","volume":"14","author":"Cai","year":"2020","journal-title":"Hepatol. Int."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"3078","DOI":"10.2169\/internalmedicine.5250-25","article-title":"Impact of the FIB4 Index on Pre-sarcopenia in Patients with Metabolic-dysfunction Associated Steatotic Liver Disease","volume":"64","author":"Nishikawa","year":"2025","journal-title":"Intern. Med."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Liang, Y., Ye, X., Pan, M., Chen, Y., Yuan, Y., and Luo, L. (2025). Impact of steatotic liver disease subtypes, sarcopenia, and fibrosis on all-cause and cause-specific mortality: A 15.7-year cohort study. BMC Gastroenterol., 25.","DOI":"10.1186\/s12876-025-03661-0"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/hepr.13453","article-title":"Clinical utility of the Liver Frailty Index for predicting muscle atrophy in chronic liver disease patients with hepatocellular carcinoma","volume":"50","author":"Hirota","year":"2020","journal-title":"Hepatol. Res."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1097\/TP.0000000000000593","article-title":"Quality of life in liver transplant candidates: Frailty is a better indicator than severity of liver disease","volume":"99","author":"Derck","year":"2015","journal-title":"Transplantation"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1097\/MEG.0000000000002895","article-title":"Fast score is associated with patient-reported outcomes in patients with metabolic dysfunction-associated steatotic liver disease","volume":"37","author":"Hashida","year":"2025","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1111\/jgh.15172","article-title":"Patient-reported outcomes in patients with non-alcoholic fatty liver disease: A narrative review of Chronic Liver Disease Questionnaire-non-alcoholic fatty liver disease\/non-alcoholic steatohepatitis","volume":"36","author":"Yamamura","year":"2021","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.jhep.2022.01.010","article-title":"Associations of muscle mass and grip strength with severe NAFLD: A prospective study of 333,295 UK Biobank participants","volume":"76","author":"Gray","year":"2022","journal-title":"J. Hepatol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/j.clnu.2022.03.022","article-title":"Skeletal muscle mass and abdominal obesity are independent predictors of hepatic steatosis and interact to predict ten-year cardiovascular disease incidence: Data from the ATTICA cohort study","volume":"41","author":"Kouvari","year":"2022","journal-title":"Clin. Nutr."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/cen.14990","article-title":"Lower creatinine to cystatin C ratio is associated with an increased risk of MASLD: A cross-sectional and prospective study of 368,634 UK Biobank participants","volume":"100","author":"Wang","year":"2024","journal-title":"Clin. Endocrinol."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Iwaki, M., Kobayashi, T., Nogami, A., Saito, S., Nakajima, A., and Yoneda, M. (2023). Impact of Sarcopenia on Non-Alcoholic Fatty Liver Disease. Nutrients, 15.","DOI":"10.3390\/nu15040891"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.jhep.2015.02.051","article-title":"Sarcopaenia is associated with NAFLD independently of obesity and insulin resistance: Nationwide surveys (KNHANES 2008\u20132011)","volume":"63","author":"Lee","year":"2015","journal-title":"J. Hepatol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1002\/hep.26716","article-title":"Relationship between sarcopenia and nonalcoholic fatty liver disease: The Korean Sarcopenic Obesity Study","volume":"59","author":"Hong","year":"2014","journal-title":"Hepatology"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Choe, E.K., Kang, H.Y., Park, B., Yang, J.I., and Kim, J.S. (2018). The Association between Nonalcoholic Fatty Liver Disease and CT-Measured Skeletal Muscle Mass. J. Clin. Med., 7.","DOI":"10.3390\/jcm7100310"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"12","DOI":"10.4103\/sjg.SJG_237_17","article-title":"Sarcopenia and risk of nonalcoholic fatty liver disease: A meta-analysis","volume":"24","author":"Wijarnpreecha","year":"2018","journal-title":"Saudi J. Gastroenterol."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Nishikawa, H., Asai, A., Fukunishi, S., Nishiguchi, S., and Higuchi, K. (2021). Metabolic Syndrome and Sarcopenia. Nutrients, 13.","DOI":"10.3390\/nu13103519"},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Rubio-Ruiz, M.E., Guarner-Lans, V., P\u00e9rez-Torres, I., and Soto, M.E. (2019). Mechanisms Underlying Metabolic Syndrome-Related Sarcopenia and Possible Therapeutic Measures. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20030647"},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Jimenez-Gutierrez, G.E., Mart\u00ednez-G\u00f3mez, L.E., Mart\u00ednez-Armenta, C., Pineda, C., Mart\u00ednez-Nava, G.A., and Lopez-Reyes, A. (2022). Molecular Mechanisms of Inflammation in Sarcopenia: Diagnosis and Therapeutic Update. Cells, 11.","DOI":"10.3390\/cells11152359"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"101700","DOI":"10.1016\/j.smrv.2022.101700","article-title":"Sleep, circadian biology and skeletal muscle interactions: Implications for metabolic health","volume":"66","author":"Morrison","year":"2022","journal-title":"Sleep Med. Rev."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.clnesp.2023.07.086","article-title":"Circadian misalignment in obesity: The role for time-restricted feeding","volume":"57","author":"Chambers","year":"2023","journal-title":"Clin. Nutr. ESPEN"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/joim.12924","article-title":"The circadian syndrome: Is the metabolic syndrome and much more!","volume":"286","author":"Zimmet","year":"2019","journal-title":"J. Intern. Med."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1152\/physiol.00003.2018","article-title":"Circadian etiology of type 2 diabetes mellitus","volume":"33","author":"Javeed","year":"2018","journal-title":"Physiology"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jhep.2019.03.020","article-title":"The circadian clock and liver function in health and disease","volume":"71","author":"Mukherji","year":"2019","journal-title":"J. Hepatol."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Rajan, P.K., Udoh, U.S., Finley, R., Pierre, S.V., and Sanabria, J. (2024). The biological clock of liver metabolism in metabolic dysfunction-associated steatohepatitis progression to hepatocellular carcinoma. Biomedicines, 12.","DOI":"10.3390\/biomedicines12091961"},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Schaeffer, S., Bogdanovic, A., Hildebrandt, T., Flint, E., Geng, A., Pecenko, S., Lussier, P., Strumberger, M.A., Meyer, M., and Weber, J. (2024). Significant nocturnal wakefulness after sleep onset in metabolic dysfunction-associated steatotic liver disease. Front. Netw. Physiol., 4.","DOI":"10.3389\/fnetp.2024.1458665"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jhep.2024.07.034","article-title":"Targeting the liver clock improves fibrosis by restoring TGF-\u03b2 signaling","volume":"82","author":"Crouchet","year":"2025","journal-title":"J. Hepatol."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Choi, Y., Cho, J., No, M.H., Heo, J.W., Cho, E.J., Chang, E., Park, D.H., Kang, J.H., and Kwak, H.B. (2020). Re-Setting the Circadian Clock Using Exercise against Sarcopenia. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21093106"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"6297651","DOI":"10.1155\/2017\/6297651","article-title":"The Common Mechanisms of Sarcopenia and NAFLD","volume":"2017","author":"Zhai","year":"2017","journal-title":"BioMed Res. Int."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/joim.12719","article-title":"Causal relationship of hepatic fat with liver damage and insulin resistance in nonalcoholic fatty liver","volume":"283","author":"Dongiovanni","year":"2018","journal-title":"J. Intern. Med."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"3637","DOI":"10.1210\/jc.2013-1519","article-title":"Resolution of fatty liver and risk of incident diabetes","volume":"98","author":"Sung","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1016\/j.cgh.2017.04.040","article-title":"Histologic Scores for Fat and Fibrosis Associate With Development of Type 2 Diabetes in Patients With Nonalcoholic Fatty Liver Disease","volume":"15","author":"Stal","year":"2017","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1152\/physrev.00033.2024","article-title":"A comprehensive view of muscle glucose uptake: Regulation by insulin, contractile activity, and exercise","volume":"105","author":"Richter","year":"2025","journal-title":"Physiol. Rev."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"667","DOI":"10.2337\/diab.37.6.667","article-title":"Lilly lecture 1987. The triumvirate: Beta-cell, muscle, liver. A collusion responsible for NIDDM","volume":"37","author":"DeFronzo","year":"1988","journal-title":"Diabetes"},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Matsui, M., Fukuda, A., Onishi, S., Ushiro, K., Nishikawa, T., Asai, A., Kim, S.K., and Nishikawa, H. (2023). Insulin Resistance: A Marker for Fat-to-Lean Body Composition in Japanese Adults. Nutrients, 15.","DOI":"10.3390\/nu15224724"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.2337\/db13-0728","article-title":"LECT2 functions as a hepatokine that links obesity to skeletal muscle insulin resistance","volume":"63","author":"Lan","year":"2014","journal-title":"Diabetes"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.cmet.2024.04.006","article-title":"Hepatic selective insulin resistance at the intersection of insulin signaling and metabolic dysfunction-associated steatotic liver disease","volume":"36","author":"Bo","year":"2024","journal-title":"Cell Metab."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.cmet.2010.09.015","article-title":"A liver-derived secretory protein, selenoprotein P, causes insulin resistance","volume":"12","author":"Misu","year":"2010","journal-title":"Cell Metab."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/nm.4295","article-title":"Deficiency of the hepatokine selenoprotein P increases responsiveness to exercise in mice through upregulation of reactive oxygen species and AMP-activated protein kinase in muscle","volume":"23","author":"Misu","year":"2017","journal-title":"Nat. Med."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.cmet.2023.01.006","article-title":"The role of hepatokines in NAFLD","volume":"35","author":"Stefan","year":"2023","journal-title":"Cell Metab."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1038\/nm.2851","article-title":"Fetuin-A acts as an endogenous ligand of TLR4 to promote lipid-induced insulin resistance","volume":"18","author":"Pal","year":"2012","journal-title":"Nat. Med."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.jhep.2013.06.004","article-title":"The role of hepassocin in the development of nonalcoholic fatty liver disease","volume":"59","author":"Wu","year":"2013","journal-title":"J. Hepatol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/j.cmet.2025.04.014","article-title":"FGF21 reverses MASH through coordinated actions on the CNS and liver","volume":"37","author":"Rose","year":"2025","journal-title":"Cell Metab."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1055\/a-1778-4159","article-title":"FGF21: A Novel Regulator of Glucose and Lipid Metabolism and Whole-Body Energy Balance","volume":"54","year":"2022","journal-title":"Horm. Metab. Res."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1210\/endrev\/bnaa016","article-title":"Muscle-Organ Crosstalk: The Emerging Roles of Myokines","volume":"41","author":"Severinsen","year":"2020","journal-title":"Endocr. Rev."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/nrrheum.2014.193","article-title":"Exercise as an anti-inflammatory therapy for rheumatic diseases-myokine regulation","volume":"11","author":"Benatti","year":"2015","journal-title":"Nat. Rev. Rheumatol."},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Nishikawa, H., Kim, S.K., and Asai, A. (2025). The Role of Myokines in Liver Diseases. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26031043"},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Fontes-Cal, T.C.M., Mattos, R.T., Medeiros, N.I., Pinto, B.F., Belchior-Bezerra, M., Roque-Souza, B., Dutra, W.O., Ferrari, T.C.A., Vidigal, P.V.T., and Faria, L.C. (2021). Crosstalk Between Plasma Cytokines, Inflammation, and Liver Damage as a New Strategy to Monitoring NAFLD Progression. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.708959"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/387083a0","article-title":"Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member","volume":"387","author":"McPherron","year":"1997","journal-title":"Nature"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1002\/jcsm.12212","article-title":"Elevated serum myostatin level is associated with worse survival in patients with liver cirrhosis","volume":"8","author":"Nishikawa","year":"2017","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Armandi, A., Rosso, C., Nicolosi, A., Caviglia, G.P., Abate, M.L., Olivero, A., D\u2019Amato, D., Vernero, M., Gaggini, M., and Saracco, G.M. (2022). Crosstalk between Irisin Levels, Liver Fibrogenesis and Liver Damage in Non-Obese, Non-Diabetic Individuals with Non-Alcoholic Fatty Liver Disease. J. Clin. Med., 11.","DOI":"10.3390\/jcm11030635"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/s41574-019-0174-x","article-title":"Physical activity and muscle-brain crosstalk","volume":"15","author":"Pedersen","year":"2019","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1249\/MSS.0000000000002064","article-title":"Sedentarism, Physical Activity, Steps, and Neurotrophic Factors in Obese Children","volume":"51","author":"Migueles","year":"2019","journal-title":"Med. Sci. Sports Exerc."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1080\/00952990.2020.1833211","article-title":"BDNF levels and liver stiffness in subjects with alcohol use disorder: Evaluation after alcohol withdrawal","volume":"47","author":"Girard","year":"2021","journal-title":"Am. J. Drug Alcohol Abus."},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Kawaguchi, T., Yoshio, S., Sakamoto, Y., Hashida, R., Koya, S., Hirota, K., Nakano, D., Yamamura, S., Niizeki, T., and Matsuse, H. (2020). Impact of Decorin on the Physical Function and Prognosis of Patients with Hepatocellular Carcinoma. J. Clin. Med., 9.","DOI":"10.3390\/jcm9040936"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.jhep.2015.05.014","article-title":"Sarcopenia in non-alcoholic fatty liver disease: Targeting the real culprit?","volume":"63","author":"Merli","year":"2015","journal-title":"J. Hepatol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1038\/s41598-021-81669-8","article-title":"Novel myostatin-specific antibody enhances muscle strength in muscle disease models","volume":"11","author":"Muramatsu","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Aggeletopoulou, I., Tsounis, E.P., and Triantos, C. (2024). Vitamin D and Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Novel Mechanistic Insights. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25094901"},{"key":"ref_83","first-page":"499","article-title":"Vitamin D and muscle health: Insights from recent studies","volume":"27","author":"Kuwabara","year":"2024","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"b3692","DOI":"10.1136\/bmj.b3692","article-title":"Fall prevention with supplemental and active forms of vitamin D: A meta-analysis of randomised controlled trials","volume":"339","author":"Staehelin","year":"2009","journal-title":"BMJ"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/bs.afnr.2023.12.006","article-title":"Vitamin D and obesity","volume":"109","author":"Park","year":"2024","journal-title":"Adv. Food Nutr. Res."},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Chen, L., Zhou, H., Gong, Y., Tang, Y., Su, H., Zhang, Z., Tong, P., and Chen, G. (2025). Clinical outcome changes in sarcopenic obesity: A meta-analysis of exercise training methods. BMC Geriatr., 25.","DOI":"10.1186\/s12877-024-05655-1"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1002\/hep.28376","article-title":"Sarcopenia is associated with significant liver fibrosis independently of obesity and insulin resistance in nonalcoholic fatty liver disease: Nationwide surveys (KNHANES 2008\u20132011)","volume":"63","author":"Lee","year":"2016","journal-title":"Hepatology"},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Nishikawa, H., Enomoto, H., Nishiguchi, S., and Iijima, H. (2021). Sarcopenic Obesity in Liver Cirrhosis: Possible Mechanism and Clinical Impact. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22041917"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1038\/s41598-025-86424-x","article-title":"BMI gain and dietary characteristics are risk factors of MASLD in non-obese individuals","volume":"15","author":"Taniguchi","year":"2025","journal-title":"Sci. Rep."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1111\/jgh.16927","article-title":"Individualized Effects of Weight Gain in Adulthood on the Development of MASLD in Japanese Non-Obese Individuals","volume":"40","author":"Fukamizo","year":"2025","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1016\/j.clnu.2017.08.018","article-title":"Lifestyle predictors of obese and non-obese patients with nonalcoholic fatty liver disease: A cross-sectional study","volume":"37","author":"Kwak","year":"2018","journal-title":"Clin. Nutr."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1016\/j.cgh.2022.11.019","article-title":"Mortality and liver-related events in lean versus non-lean nonalcoholic fatty liver disease: A systematic review and meta-analysis","volume":"21","author":"Ha","year":"2023","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global burden of NAFLD and NASH: Trends, predictions, risk factors and prevention","volume":"15","author":"Younossi","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/ajg.2016.318","article-title":"Clinical and Metabolic Characterization of Lean Caucasian Subjects with Non-alcoholic Fatty Liver","volume":"112","author":"Feldman","year":"2017","journal-title":"Am. J. Gastroenterol."},{"key":"ref_95","doi-asserted-by":"crossref","unstructured":"Burgess, K., Xu, T., Brown, R., Han, B., and Welle, S. (2011). Effect of myostatin depletion on weight gain, hyperglycemia, and hepatic steatosis during five months of high-fat feeding in mice. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0017090"},{"key":"ref_96","doi-asserted-by":"crossref","unstructured":"Yu, R., Shi, Q., Liu, L., and Chen, L. (2018). Relationship of sarcopenia with steatohepatitis and advanced liver fibrosis in nonalcoholic fatty liver disease: A meta-analysis. BMC Gastroenterol., 18.","DOI":"10.1186\/s12876-018-0776-0"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1111\/jgh.14585","article-title":"Characteristics of non-alcoholic steatohepatitis among lean patients in Japan: Not uncommon and not always benign","volume":"34","author":"Tobari","year":"2019","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_98","doi-asserted-by":"crossref","unstructured":"Onishi, S., Fukuda, A., Matsui, M., Ushiro, K., Nishikawa, T., Asai, A., Kim, S.K., and Nishikawa, H. (2023). Body Composition Analysis in Patients with Metabolic Dysfunction-Associated Fatty Liver Disease. Nutrients, 15.","DOI":"10.3390\/nu15183878"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1111\/hepr.13543","article-title":"Clinical and anthropometric characteristics of non-obese non-alcoholic fatty liver disease subjects in Japan","volume":"50","author":"Shida","year":"2020","journal-title":"Hepatol. Res."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"e0711","DOI":"10.1097\/HC9.0000000000000711","article-title":"Skeletal muscle and MASLD: Mechanistic and clinical insights","volume":"9","author":"Marjot","year":"2025","journal-title":"Hepatol. Commun."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1002\/jcsm.13543","article-title":"Association between metabolic dysfunction-associated steatotic liver disease and myosteatosis measured by computed tomography","volume":"15","author":"Kim","year":"2024","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"155639","DOI":"10.1016\/j.metabol.2023.155639","article-title":"Sarcopenic obesity: Emerging mechanisms and therapeutic potential","volume":"146","author":"Axelrod","year":"2023","journal-title":"Metabolism"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1111\/add.14703","article-title":"Alcohol use disorders and the heart","volume":"114","author":"Day","year":"2019","journal-title":"Addiction"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/S2468-1253(23)00206-6","article-title":"Met-ALD: New opportunities to understand the role of alcohol in steatotic liver disease","volume":"8","author":"Israelsen","year":"2023","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s00223-023-01081-4","article-title":"Alcohol Consumption and Measures of Sarcopenic Muscle Risk: Cross-Sectional and Prospective Associations Within the UK Biobank Study","volume":"113","author":"Skinner","year":"2023","journal-title":"Calcif. Tissue Int."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1111\/acer.13425","article-title":"Sarcopenia in Alcoholic Liver Disease: Clinical and Molecular Advances","volume":"41","author":"Dasarathy","year":"2017","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1016\/j.bbadis.2015.03.006","article-title":"On the mechanism underlying ethanol-induced mitochondrial dynamic disruption and autophagy response","volume":"1852","author":"Barcia","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_108","doi-asserted-by":"crossref","unstructured":"Matsui, M., Fukuda, A., Onishi, S., Ushiro, K., Nishikawa, T., Asai, A., Kim, S.K., and Nishikawa, H. (2025). Impact of Alcohol Intake on Body Composition in Patients with Steatotic Liver Disease. Nutrients, 17.","DOI":"10.3390\/nu17061092"},{"key":"ref_109","doi-asserted-by":"crossref","unstructured":"Zhang, S., Qi, Z., Wang, Y., Song, D., and Zhu, D. (2023). Effect of sodium-glucose transporter 2 inhibitors on sarcopenia in patients with type 2 diabetes mellitus: A systematic review and meta-analysis. Front. Endocrinol., 14.","DOI":"10.3389\/fendo.2023.1203666"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1016\/j.clnu.2023.10.004","article-title":"Sodium-glucose co-transporter 2 inhibitors and Sarcopenia: A controversy that must be solved","volume":"42","author":"Afsar","year":"2023","journal-title":"Clin. Nutr."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1056\/NEJMoa2413258","article-title":"Phase 3 Trial of Semaglutide in Metabolic Dysfunction-Associated Steatohepatitis","volume":"392","author":"Sanyal","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1111\/hepr.14087","article-title":"Changes in alanine aminotransferase and body composition and metabolic factors among individuals receiving medical health checkups","volume":"54","author":"Onishi","year":"2024","journal-title":"Hepatol. Res."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"e270723219177","DOI":"10.2174\/1573399820666230727101141","article-title":"Metformin in Type 2 Diabetes: Evidence for its Beneficial Effects on Frailty and Sarcopenia","volume":"20","author":"Pyrgioti","year":"2024","journal-title":"Curr. Diabetes Rev."},{"key":"ref_114","doi-asserted-by":"crossref","unstructured":"Cui, X., Liu, H., Liu, Y., Yu, Z., Wang, D., Wei, W., and Wang, S. (2025). The role and mechanisms of myokines in sarcopenia: New intervention strategies for the challenges of aging. Front. Med., 12.","DOI":"10.3389\/fmed.2025.1665708"},{"key":"ref_115","doi-asserted-by":"crossref","unstructured":"Lee, D.Y., and Shin, S. (2023). Sarcopenia and Anemia in Elderly Koreans: A Nationwide Population-Based Study. Healthcare, 11.","DOI":"10.3390\/healthcare11172428"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1007\/s40520-021-01942-8","article-title":"Post-COVID-19 acute sarcopenia: Physiopathology and management","volume":"33","author":"Piotrowicz","year":"2021","journal-title":"Aging Clin. Exp. Res."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"e186420","DOI":"10.1172\/JCI186420","article-title":"MASH: The nexus of metabolism, inflammation, and fibrosis","volume":"135","author":"Steinberg","year":"2025","journal-title":"J. Clin. Investig."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"e28123","DOI":"10.1016\/j.heliyon.2024.e28123","article-title":"Spleen volume is independently associated with non-alcoholic fatty liver disease, liver volume and liver fibrosis","volume":"10","author":"Helgesson","year":"2024","journal-title":"Heliyon"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1002\/hep.31158","article-title":"Inadequate Physical Activity and Sedentary Behavior Are Independent Predictors of Nonalcoholic Fatty Liver Disease","volume":"72","author":"Kim","year":"2020","journal-title":"Hepatology"},{"key":"ref_120","doi-asserted-by":"crossref","unstructured":"Yamaoka, T., Araki, A., Tamura, Y., Tanaka, S., Fujihara, K., Horikawa, C., Aida, R., Kamada, C., Yoshimura, Y., and Moriya, T. (2020). Association between Low Protein Intake and Mortality in Patients with Type 2 Diabetes. Nutrients, 12.","DOI":"10.3390\/nu12061629"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1093\/nutrit\/nuaa145","article-title":"Comparison of calorie and nutrient intake among elderly with and without sarcopenia: A systematic review and meta-analysis","volume":"79","author":"Santiago","year":"2021","journal-title":"Nutr. Rev."},{"key":"ref_122","doi-asserted-by":"crossref","unstructured":"European Association for the Study of the Liver (2019). EASL clinical practice guidelines on nutrition in chronic liver disease. J. Hepatol., 70, 172\u2013193.","DOI":"10.1016\/j.jhep.2018.06.024"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.cgh.2020.10.034","article-title":"AGA clinical practice update on bariatric surgery in cirrhosis: Expert review","volume":"19","author":"Patton","year":"2021","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1007\/s00535-021-01833-9","article-title":"Clinical practice advice on lifestyle modification in the management of nonalcoholic fatty liver disease in Japan: An expert review","volume":"56","author":"Kamada","year":"2021","journal-title":"J. Gastroenterol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1053\/j.gastro.2020.11.051","article-title":"AGA Clinical Practice Update on Lifestyle Modification Using Diet and Exercise to Achieve Weight Loss in the Management of Nonalcoholic Fatty Liver Disease: Expert Review","volume":"160","author":"Younossi","year":"2021","journal-title":"Gastroenterology"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1038\/sj.ijo.0803683","article-title":"A dose-response relation between aerobic exercise and visceral fat reduction: Systematic review of clinical trials","volume":"31","author":"Ohkawara","year":"2007","journal-title":"Int. J. Obes."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jhep.2016.08.023","article-title":"Aerobic vs. resistance exercise in non-alcoholic fatty liver disease: A systematic review","volume":"66","author":"Hashida","year":"2017","journal-title":"J. Hepatol."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"100411","DOI":"10.1016\/j.jhepr.2021.100411","article-title":"Real-world management of non-alcoholic steatohepatitis differs from clinical practice guideline recommendations and across regions","volume":"4","author":"Anstee","year":"2021","journal-title":"JHEP Rep."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"112720","DOI":"10.1016\/j.exger.2025.112720","article-title":"Effects of green tea catechins and exercise on age-related muscle atrophy and satellite cell functions in a mouse model of sarcopenia","volume":"202","author":"Matsuzaki","year":"2025","journal-title":"Exp. Gerontol."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"101","DOI":"10.4103\/CJP.CJP_95_19","article-title":"Combination of exercise training and resveratrol attenuates obese sarcopenia in skeletal muscle atrophy","volume":"63","author":"Bai","year":"2020","journal-title":"Chin. J. Physiol."},{"key":"ref_131","doi-asserted-by":"crossref","unstructured":"Putra, C., Konow, N., Gage, M., York, C.G., and Mangano, K.M. (2021). Protein Source and Muscle Health in Older Adults: A Literature Review. Nutrients, 13.","DOI":"10.3390\/nu13030743"},{"key":"ref_132","first-page":"469","article-title":"Effects of curcumin supplementation on exercise-induced oxidative stress in humans","volume":"35","author":"Takahashi","year":"2014","journal-title":"Int. J. Sports Med."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"104108","DOI":"10.1016\/j.archger.2020.104108","article-title":"The effect of Korean Red Ginseng on sarcopenia biomarkers in type 2 diabetes patients","volume":"90","author":"Park","year":"2020","journal-title":"Arch. Gerontol. Geriatr."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"2772","DOI":"10.1002\/jcsm.13057","article-title":"The beneficial therapeutic effects of plant-derived natural products for the treatment of sarcopenia","volume":"13","author":"Bagherniya","year":"2022","journal-title":"J. Cachexia Sarcopenia Muscle"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/4\/1661\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T09:21:53Z","timestamp":1771838513000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/4\/1661"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,23]]},"references-count":134,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,2]]}},"alternative-id":["jcm15041661"],"URL":"https:\/\/doi.org\/10.3390\/jcm15041661","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,23]]}}}